Drug Index

Cobicistat

 
print

Mechanism :

Cobicistat is a mechanism-based inhibitor of cytochrome P450 3A (CYP3A).
Inhibition of CYP3A-mediated metabolism by cobicistat and increases the systemic exposure of CYP3A substrates atazanavir and darunavir.


Indication :

• Treatment of HIV-1 infection to increase systemic exposure of atazanavir or darunavir (once-daily dosing regimen)


Contraindications :

Concomitant use of cobicistat with atazanavir or darunavir with alfuzosin, carbamazepine, cisapride, colchicine (in patients with renal and/or hepatic impairment), dronedarone, ergot derivatives (e.g., dihydroergotamine, ergotamine, methylergonovine), lovastatin, lurasidone, midazolam (oral), phenobarbital, phenytoin, pimozide, ranolazine, rifampin, sildenafil (when used for pulmonary arterial hypertension), simvastatin, St. John wort, triazolam; concomitant use of cobicistat and atazanavir with drospirenone/ethinyl estradiol, indinavir, irinotecan, or nevirapine.


Dosing :

Safety and efficacy not established in pediatric patients.

Adults: With atazanavir 300 mg give 150 mg PO OD.

With darunavir 800 mg give 150 mg PO OD.


Adverse Effect :

Hyperbilirubinemia, increased creatine kinase, rash, increased serum amylase, GGT, AST and ALT, glycosuria, hematuria, nausea, diarrhea, vomiting, fatigue, rhabdomyolysis, depression, insomnia.


Interaction :

CYP3A4 Inducers: May increase the metabolism of CYP3A4 Substrates.
CYP3A4 Substrates: CYP3A4 Inhibitors may decrease the metabolism of CYP3A4 Substrates .
Dexamethasone (Systemic): May decrease the serum concentration of Cobicistat.
Digoxin: Cobicistat may increase the serum concentration of Digoxin.
Warfarin: Cobicistat may increase the serum concentration of Warfarin.


07/14/2019 15:31:50 Cobicistat
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0